Our previous transcriptomic profiling study has shown that differentially expressed genes in tumor resistance are enriched in the biological processes related to angiogenesis and inhibition of VEGF-C in resistant tumor cells can restore sensitivity to anti-VEGF therapy[16]. This evidence concerns the gene VEGFC and neoplasm.